TransCode adjourns special meeting due to lack of quorum; reconvenes May 2 for reverse split vote

Transcode Therapeutics, Inc.

Only 12.73% of outstanding shares voted at April 21 special meeting; quorum required one-third.
Adjourned meeting reconvenes May 2, 2025 at 9:30 a.m. ET virtually at www.virtualshareholdermeeting.com/RNAZ2025SM2.
Proposal 1: reverse stock split at ratio from 1:10 to 1:40, board discretion.
Proposal 2: adjournment if needed; record date still April 2, 2025.
New vote deadline May 1, 2025 at 11:59 p.m. ET; company continues solicitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.